Just Launched Campaigns

KarbonPay on Republic

Karbonpay is a B2B SaaS platform focusing on simplifying global payroll processes. It's designed to handle the complexities of payroll calculations and compliance across multiple countries. The platform has gained significant traction in the market, with features that automate critical compliance calculations and provide consolidated data for better decision-making.

Key Highlights

1. Market Performance and Growth: Karbonpay has shown impressive growth with around 600 monthly paying customers and an average of 220 inbound trial signups monthly. It has processed over $90,000,000 in payroll and exhibits a 40% year-over-year growth.

2. Awards and Recognition: The platform has been recognized for its innovation and efficiency, winning the Go Global Awards in Fintech 2021 and being listed among the top 10 HR tech startups in HR Tech Magazine.

3. Product Features: Karbonpay offers a cloud-based web platform that consolidates multi-country payroll. Key features include a global dashboard for international payroll overview, customizable reporting capabilities, and a transparent, flexible pricing model.

4. Investment Opportunity: The platform is currently open for investment with a minimum investment of $150. The funding goal is set at $4.38 million, with a valuation cap of $15 million and a 10% discount for investors.

Loper on Wefunder

Loper is an educational advisor application, positioned as a tool to optimize the allocation of high school graduates to colleges best suited for them. The platform is currently open for investment on Wefunder, with a public launch scheduled. Loper has garnered attention and investment from entities like 5150 Capital, Gener8tor, ECMC Group, and Ken Ruggiero, CEO/Founder of Ascent Funding. The company's valuation cap is set at $5M, and it's based in Chicago, IL.

Key Highlights

1. Financial Growth and Projections: Loper has demonstrated significant financial growth, with $105K in revenue and $128K in Annual Recurring Revenue (ARR), projecting more than a 5x increase for 2024 (though this is not guaranteed).

2. Expanding Customer Base: The company has successfully onboarded 11 college customers and conducted 3 paid trials in December, with all customers re-signing, indicating strong market acceptance and potential for further growth.

3. User Engagement: The app has achieved 115K downloads, with over 25K since Labor Day, and a 380% year-over-year peak season user growth, highlighting its increasing popularity and user engagement.

4. Recognition and Team Expertise: Loper has been recognized in the Holoniq 2023 North America EdTech 200 and the GSV Cup Elite 200 EdTech startup list. The team includes experienced professionals like Sam Bernstein (Co-founder and CEO) and Eric Menna (Co-founder and COO), showcasing a strong foundation for future development.

Trending Campaigns

Zyppah on Dealmaker

Zyppah is a company that has developed a patented mouthguard, which they claim has a 91% success rate in stopping snoring, as proven in an FDA-approved clinical study. They are seeking investors to join them as they aim to scale and become the leading brand in sleep solutions.

Key Highlights

1. Market Potential: Zyppah targets a large market with over 100 million snorers in the U.S. alone, presenting a significant revenue opportunity.

2. Proven Success: The company has achieved over $55 million in sales and their FDA-cleared mouthguard has a 91% success rate in stopping snoring.

3. Investor Perks: Zyppah offers various perks for investors, including bonus shares and exclusive products.

4. Expansion Plans: Plans to expand into more sleep-related products and increase international presence.

Place Technology on Wefunder

Place Technology, is a company that aims to address revenue challenges by integrating sales, revenue, billing, and finance. They have raised over $1.64 million from 15 investors. The investment is structured as a convertible note with a $20 million valuation cap and a 20% discount. Place Technology, based in Austin, TX, operates in the technology, fintech, and finance sectors, focusing on B2B solutions.

Key Highlights

1. New RevOps Product: Place Technology has developed a new product in the revenue operations (RevOps) space, which is a little over a year old. They plan to launch two additional versions soon.

2. Market Potential: The company estimates a $7 billion addressable market in their sector, with no dominant player currently leading the market.

3. Strong Sales Performance: The first quarter of 2023 was their strongest first quarter in sales, ranking fourth best of all time.

4. Revenue Growth: There has been a 64% surge in revenue year-over-year, comparing May 2023 to May 2022.

Campaigns Closing Soon

Invicta Water on NetCapital

Invicta Water aims to remove PFAS from water worldwide, seeing clean water as a basic right. They use innovative, eco-friendly technology for this purpose. Currently, they're on Netcapital for investment, with a minimum of $99 and a deadline of February 29, 2024.

Key Highlights

1. PFAS Challenge: Invicta Water addresses the widespread contamination of water by PFAS, harmful chemicals linked to serious health issues.

2. Regulation Response: The company's technology aligns with new EPA regulations aiming to control PFAS levels in drinking water.

3. Innovative Technology: Utilizes catalytic crystals and UV energy to efficiently and safely destroy PFAS in water.

4. Versatile Business Model: Offers scalable and cost-effective water treatment solutions for various sectors, including municipal and residential.

Aspire Biopharm on Republic

Aspire Biopharma, has developed a new drug formulation for fast absorption through the mouth, bypassing the digestive system. This technology promises quicker delivery with less impact on the liver and stomach. Their first product, Instaprin, is an aspirin-based solution for cardiac emergencies, acute pain, and inflammation.

Key Highlights

1. Innovative Drug Delivery Technology: Aspire Biopharma's technology enables rapid and direct absorption of medicine into the bloodstream, offering a safer and more effective alternative to traditional pill intake.

2. Instaprin - The Flagship Product: Instaprin, an aspirin formulation, is designed for rapid response in cardiology emergencies, stroke, and pain management, utilizing a sublingual delivery method to avoid gastrointestinal damage.

3. Manufacturing and Business Strategy: The company is pursuing a contract manufacturing strategy, collaborating with experienced suppliers to mitigate risks and capital investments associated with manufacturing facilities.

4. Market Opportunity and Opioid Crisis Solution: Instaprin is positioned as an alternative to opioids, addressing the significant health crisis caused by opioid misuse. The company is in discussions with regulatory bodies to fast-track Instaprin's approval, leveraging anti-opioid initiatives.

Spotlight Deal Review